Last reviewed · How we verify
Right-sided Staphylococcus aureus endocarditis
Approved treatments
- Cubicin · Baxter
Daptomycin is an antibacterial drug with lipopeptide structure. - Cubicin · Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- DAPT · Baxter Hlthcare Corp
Dapt is a small molecule that works by interacting with specific biological targets, but the exact details of this interaction are unknown.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Right-sided Staphylococcus aureus endocarditis patent landscape — cliff calendar, originator estates, attackable patents
- Right-sided Staphylococcus aureus endocarditis treatment landscape brief
- Right-sided Staphylococcus aureus endocarditis treatment updates RSS
Frequently asked questions about Right-sided Staphylococcus aureus endocarditis
What drugs treat Right-sided Staphylococcus aureus endocarditis?
Tracked treatments include Cubicin, DAPT.
What is the treatment for Right-sided Staphylococcus aureus endocarditis?
Standard treatment for Right-sided Staphylococcus aureus endocarditis includes Cubicin, DAPT. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Right-sided Staphylococcus aureus endocarditis patent cliff · Right-sided Staphylococcus aureus endocarditis CI report
- Treatment: Cubicin · Baxter
- Treatment: Cubicin · Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- Treatment: DAPT · Baxter Hlthcare Corp
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing